Wednesday, August 09, 2017 2:44:44 PM
It would appear GW is being very Rude about protecting Epidiolex -->
https://hoban.law/blog/2017/2017-02/gw-pharmaceuticals-shot-across-bow-americas-hemp-and-cbd-industries
Thoughts on how this could effect NB2?
Also, did anyone see how GW has delayed completed their NDA for Epidiolex because of construction at a new extraction facility? If only there was a quicker and cheaper way To manufacture....
https://seekingalpha.com/article/4096071-gw-pharmaceuticals-gwph-ceo-justin-gover-q3-2017-results-earnings-call-transcript?part=single
Also, no mention of Sativex during the call. Swing and a Miss
Recent SKYE News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:19:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:02:13 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM